Literature DB >> 26988744

A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration.

Dominic M Walsh1, Dennis J Selkoe1.   

Abstract

There has been an explosion in the number of papers discussing the hypothesis of 'pathogenic spread' in neurodegenerative disease - the idea that abnormal forms of disease-associated proteins, such as tau or α-synuclein, physically move from neuron to neuron to induce disease progression. However, whether inter-neuronal spread of protein aggregates actually occurs in humans and, if so, whether it causes symptom onset remain uncertain. Even if pathogenic spread is proven in humans, it is unclear how much this would alter the specific therapeutic approaches that are in development. A critical appraisal of this increasingly popular hypothesis thus seems both important and timely.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26988744      PMCID: PMC6701169          DOI: 10.1038/nrn.2016.13

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  143 in total

1.  Tau transgenic mice as models for cerebrospinal fluid tau biomarkers.

Authors:  Donna M Barten; Gregory W Cadelina; Nina Hoque; Lynn B DeCarr; Valerie L Guss; Ling Yang; Sethu Sankaranarayanan; Paul D Wes; Marianne E Flynn; Jere E Meredith; Michael K Ahlijanian; Charles F Albright
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

3.  Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex.

Authors:  Michael J Yetman; Sveinung Lillehaug; Jan G Bjaalie; Trygve B Leergaard; Joanna L Jankowsky
Journal:  Brain Struct Funct       Date:  2015-04-14       Impact factor: 3.270

4.  Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).

Authors:  Younhee Cho; Aleksandra Baranczak; Stephen Helmke; Sergio Teruya; Evelyn M Horn; Mathew S Maurer; Jeffery W Kelly
Journal:  Amyloid       Date:  2015-07-25       Impact factor: 7.141

5.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

6.  Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin.

Authors:  Hans Zempel; Julia Luedtke; Yatender Kumar; Jacek Biernat; Hana Dawson; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  EMBO J       Date:  2013-09-24       Impact factor: 11.598

Review 7.  Role of tau protein in both physiological and pathological conditions.

Authors:  Jesus Avila; Jose J Lucas; Mar Perez; Felix Hernandez
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

8.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

9.  Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.

Authors:  Marija Usenovic; Shahriar Niroomand; Robert E Drolet; Lihang Yao; Renee C Gaspar; Nathan G Hatcher; Joel Schachter; John J Renger; Sophie Parmentier-Batteur
Journal:  J Neurosci       Date:  2015-10-21       Impact factor: 6.167

10.  Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin.

Authors:  Sabrina Cronier; Nathalie Gros; M Howard Tattum; Graham S Jackson; Anthony R Clarke; John Collinge; Jonathan D F Wadsworth
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

View more
  111 in total

1.  Taking a Bite Out of Amyloid: Mechanistic Insights into α-Synuclein Degradation by Cathepsin L.

Authors:  Ryan P McGlinchey; Gifty A Dominah; Jennifer C Lee
Journal:  Biochemistry       Date:  2017-06-28       Impact factor: 3.162

Review 2.  Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.

Authors:  D James Surmeier; Glenda M Halliday; Tanya Simuni
Journal:  Exp Neurol       Date:  2017-08-02       Impact factor: 5.330

Review 3.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

Review 4.  The activities of amyloids from a structural perspective.

Authors:  Roland Riek; David S Eisenberg
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 5.  Defects in trafficking bridge Parkinson's disease pathology and genetics.

Authors:  Asa Abeliovich; Aaron D Gitler
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

6.  PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity.

Authors:  David Mengel; Wei Hong; Grant T Corbett; Wen Liu; Alexandra DeSousa; Laura Solforosi; Cheng Fang; Matthew P Frosch; John Collinge; David A Harris; Dominic M Walsh
Journal:  Brain Res       Date:  2018-12-26       Impact factor: 3.252

Review 7.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

Review 8.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

9.  Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo.

Authors:  Tomas Ondrejcak; Igor Klyubin; Grant T Corbett; Graham Fraser; Wei Hong; Alexandra J Mably; Matthew Gardener; Jayne Hammersley; Michael S Perkinton; Andrew Billinton; Dominic M Walsh; Michael J Rowan
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

10.  E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.

Authors:  Ignacio Íñigo-Marco; Miguel Valencia; Laura Larrea; Ricardo Bugallo; Mikel Martínez-Goikoetxea; Iker Zuriguel; Montserrat Arrasate
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.